Impact of Jan Aushadhi Yojana On Branded Medicine Sal: A Comprehensive Review

References

[1] Lavtepatil S, Ghosh S. Improving access to medicines by popularising generics: a study of India’s People’s Medicine scheme in two districts of Maharashtra. BMC Health Serv Res. 2022;22(1):1-15.

[2] Bhuyan A, Patnaik BCM, Satpathy I. Review of literature on Pradhan Mantri Jan Aushodhi Pariyojana. J Orient Inst. 2024;73(2):360-375.

[3] Dolas N, Mishra G, Gatne R. Evaluation of patients' perceptions towards Jan Aushadhi Pariyojana in Mumbai and the suburbs. J Neonatal Surg. 2025;14(1):1-9.

[4] Ugandar RE, Reddy ASK. The impact of Pradhan Mantri Bhartiya Janaushadhi Pariyojana on public health and the pharmaceutical industry: a comprehensive meta-analysis. Indian J Public Health. 2026;70(1):84-89.

[5] Pareek M, Prakash M. Providing generic medicines to the poor in India: an overall assessment of government-run generic medicine scheme PMBJP. Int J Res Anal Rev. 2019;6(2):22-30.

[6] Kaul E, Gupta P. Survey of the Jan Pariyojana Scheme in India and its impact on citizens during the previous decade. Int J Drug Regul Aff. 2022;10(4):45-52.

[7] Mandlik K, Bhangale C. Generic medicine: current scenario in India. Asian J Pharm Res Dev. 2025;13(6):55-63.

[8] Behera DK, Rahut DB, Mehboobali MD, Tasneem SH, Rajendhran A. Medicine affordability and access in India: lessons from generic-branded price variation under the Jan Aushadhi Scheme. Health Policy Technol. 2025;14(2):101-115.

[9] Government of India. Pradhan Mantri Bhartiya Janaushadhi Pariyojana Guidelines. New Delhi: Department of Pharmaceuticals; 2024.

[10] World Health Organization. Generic medicines and healthcare affordability. Geneva: WHO; 2021.

[11] Gupta R, Sharma P. Generic medicines and healthcare economics in India. Indian J Pharm Pract. 2021;14(3):201-208.

[12] Singh A, Kumar V. Public awareness regarding Jan Aushadhi medicines in India. Int J Community Med Public Health. 2020;7(9):3401-3407.

[13] Patel H, Shah D. Impact of generic medicines on branded drug sales in India. Int J Pharm Sci Rev Res. 2022;73(1):120-126.

[14] Joshi R, Verma N. Pharmaceutical marketing and generic substitution trends in India. J Pharm Policy Pract. 2023;16(1):77-85.

[15] Rao M, Iyer S. Affordability of essential medicines under PMBJP. Indian J Health Econ. 2021;9(2):98-110.

[16] Chatterjee S, Banerjee T. Public perception of generic medicines in India. Asian J Pharm Clin Res. 2020;13(11):150-156.

[17] Sharma K, Mishra P. Role of pharmacists in promotion of generic medicines. Int J Pharm Pract. 2021;29(4):315-322.

[18] Kumar P, Yadav R. Impact of government healthcare schemes on pharmaceutical industry. Indian Drugs. 2022;59(5):20-28.

[19] Singh S, Arora M. Generic prescribing practices among physicians in India. Natl Med J India. 2021;34(6):340-346.

[20] Das A, Roy S. Jan Aushadhi scheme and medicine accessibility in rural India. Rural Remote Health. 2023;23(2):7001.

[21] Patel R, Mehta N. Comparative evaluation of branded and generic medicines. Int J Pharm Investig. 2020;10(4):400-407.

[22] Bhattacharya A, Sen D. Healthcare expenditure and medicine affordability in India. Health Econ Rev. 2021;11(1):25-34.

[23] Jain M, Agarwal P. Consumer trust toward generic medicines in India. Int J Res Pharm Sci. 2022;13(3):1880-1887.

[24] Thomas J, George M. Pharmaceutical policy reforms and generic drug promotion in India. J Health Manag. 2023;25(1):67-78.

@article{1718073,
      author = {Ritik Yadav, Vishal Yadav, Vivek Rawat, Ankush Pal, Ashvani Kumar; Hakim Singh Rajput},
      title = {Impact of Jan Aushadhi Yojana On Branded Medicine Sal: A Comprehensive Review},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {2217-2224},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718073.pdf},
      abstract = {The pharmaceutical sector in India is one of the largest in the world and plays a major role in supplying affordable medicines globally. However, the high cost of branded medicines has remained a major concern for Indian patients, especially low- and middle-income populations. To address this issue, the Government of India launched the Jan Aushadhi Scheme in 2008, later restructured as the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). The scheme aims to provide quality generic medicines at affordable prices through dedicated Jan Aushadhi Kendras. The increasing popularity of generic medicines under PMBJP has significantly influenced the sale of branded medicines in India. This review paper examines the impact of Jan Aushadhi Yojana on branded medicine sales, prescribing behavior, healthcare expenditure, patient perception, pharmaceutical marketing strategies, and the future of generic medicine promotion in India. The review also discusses challenges such as quality perception, awareness, stock availability, and resistance from pharmaceutical companies. The study concludes that PMBJP has contributed to reducing dependence on expensive branded medicines and promoted affordability and accessibility of healthcare in India.},
      keywords = {Jan Aushadhi Yojana, PMBJP, Generic Medicines, Branded Medicines, Pharmaceutical Industry, Healthcare Affordability, Drug Pricing, Prescription Pattern, India, Pharmaceutical Marketing},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1718073}
  }